Table 2 Hormonal profile and ultrasound measurements in treatment groups
From: Addition of low dose hCG to rFSh benefits older women during ovarian stimulation for IVF
Group 1-A r FSH + Low dose hCG < 40 y N = 49 | Group 2-A r FSH < 40 y N = 67 | P Value | Group 1-B r FSH + Low dose hCG ≥ 40 y N = 39 | Group 2-B r FSH ≥ 40 y N = 32 | P Value | |
|---|---|---|---|---|---|---|
CD3 FSH (IU/L) | 5.38 ± 2.61 | 5.78 ± 3.26 | 0.243 | 6.97 ± 2.1 | 7.42 ± 2.78 | 0.232 |
CD3 LH (IU/L) | 3.55 ± 2.61 | 3.67 ± 0.58 | 0.19 | 3.63 ± 2.02 | 4.37 ± 2.85 | 0.119 |
CD3 E2 (pmol/L) | 112.23 ± 131.99 | 114.73 ± 51.89 | 0.451 | 120.39 ± 105.46 | 123.84 ± 37.04 | 0.426 |
CD 3 Progesterone (nmol/L) | 4.13 ± 2.42 | 3.33 ± 2.23 | 0.063 | 4.21 ± 2.07 | 5.57 ± 4.48 | 0.066 |
FSH (IU/ML) on day of HCG admin | 13.35 ± 5.14 | 14.38 ± 6.35 | 0.486 | 17.38 ± 4.93 | 19.96 ± 5.83 | 0.037 |
Estradiol (pmol/L) on day of HCG admin | 8354.51 ± 4171.09 | 8226.81 ± 5262.10 | 0.443 | 8692.51 ±4174.06 | 6858.54 ± 3461.78 | 0.027 |
Estradiol (pmol/L) at HCG admin/Mature egg | 1296.84 ± 1154.87 | 935.25 ± 436.13 | 0.025 | 1933.70 ± 1475.24 | 2214.41 ± 1946.52 | 0.265 |
Progesterone (nmol/L) on day of HCG admin | 8.54 ± 4.23 | 6.87 ± 3.49 | 0.016 | 7.59 ± 3.88 | 6.48 ± 2.38 | 0.081 |
Endometrial thickness (mm) on day of HCG admin | 1.02 ± 0.27 | 1.04 ± 0.25 | 0.336 | 0.98 ± 0.25 | 0.921 ± .026 | 0.125 |